XML 16 R7.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net loss $ (145,515) $ (117,298)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 1,295 1,205
Stock-based compensation expense 19,724 19,405
Amortization of operating leases, right-of-use assets 1,000 941
Net amortization (accretion) of premiums (discounts) on marketable securities (739) 1,185
Amortization of long-term debt discount and issuance costs 63  
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 2,235 (1,694)
Other assets 0 (2)
Accounts payable 4,612 (1,680)
Accrued expenses and other current liabilities (2,979) 3,377
Operating lease liability (758) (669)
Other liabilities 9  
Net cash used in operating activities (121,053) (95,230)
Cash flows from investing activities:    
Purchases of property and equipment (678) (218)
Purchases of marketable securities (67,883) (223,411)
Maturities and sales of marketable securities 146,850 140,048
Net cash provided by (used in) investing activities 78,289 (83,581)
Cash flows from financing activities:    
Proceeds from long-term debt 49,291  
Payment of debt issuance costs (2,069)  
Proceeds from issuance of common stock under ATM, net of issuance costs of $0.7 million 24,250  
Proceeds from issuance of common stock and Series B Preferred Stock in connection with the Private Placement, net of offering costs $11.6 million 0 213,336
Proceeds from issuance of common stock upon stock option exercises 141 109
Proceeds from issuance of stock from employee stock purchase plan 584 356
Net cash provided by financing activities 72,197 213,801
Net increase in cash, cash equivalents and restricted cash 29,433 34,990
Cash, cash equivalents and restricted cash at beginning of period 98,165 53,229
Cash, cash equivalents and restricted cash at end of period 127,598 88,219
Supplemental disclosure of cash flow information:    
Cash paid for interest 252  
Supplemental disclosure of noncash investing and financing information:    
Debt discount included in accrued expenses and other liabilities 3,100  
Debt issuance costs included in accounts payable and accrued expenses 236  
Offering costs included in accounts payable and accrued expenses 0 49
Series A Preferred Stock [Member]    
Supplemental disclosure of noncash investing and financing information:    
Conversion of Series Preferred Stock into common shares 2,685  
Series B Preferred Stock [Member]    
Supplemental disclosure of noncash investing and financing information:    
Conversion of Series Preferred Stock into common shares $ 0 $ 107,980